Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Azad

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
The Journal of Clinical Investigation|December 15, 2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancersMark Yarchoan, Leslie Cope, Amanda N Ruggieri, et al.
The New England Journal of Medicine|June 2, 2015
PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyDung T Le, Jennifer N Uram, Hao Wang, et al.
JCI Insight|June 26, 2025
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasiaMelissa R Lyman, Jacob T Mitchell, Sidharth Raghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.
Science (New York, N.Y.)|June 10, 2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T Le, Jennifer N Durham, Kellie N Smith, et al.
Science Translational Medicine|February 21, 2014
Detection of circulating tumor DNA in early- and late-stage human malignanciesChetan Bettegowda, Mark Sausen, Rebecca J Leary, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
The Journal of Clinical Investigation|December 15, 2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancersMark Yarchoan, Leslie Cope, Amanda N Ruggieri, et al.
The New England Journal of Medicine|June 2, 2015
PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyDung T Le, Jennifer N Uram, Hao Wang, et al.
JCI Insight|June 26, 2025
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasiaMelissa R Lyman, Jacob T Mitchell, Sidharth Raghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.
Science (New York, N.Y.)|June 10, 2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T Le, Jennifer N Durham, Kellie N Smith, et al.
Science Translational Medicine|February 21, 2014
Detection of circulating tumor DNA in early- and late-stage human malignanciesChetan Bettegowda, Mark Sausen, Rebecca J Leary, et al.
Pageof 20